Kymera Therapeutics, Inc.

NASDAQ:KYMR

Biotechnology

Healthcare
$119.39 +1.67%

+$1.50 today

Market cap
$10.19B
Beta
2.03
P/E (TTM)
-28.3
EPS (TTM)
-$3.23
52W Low $36.65High $103.00

Volume 0.72M

Average 0.58M

Private 5-step workspace

Build a KYMR investment thesis

Turn Kymera Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.